Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

These 2 No-Brainer Growth Stocks Are Breaking New Ground

TheMotleyFool 
0 0 16.05.24
These 2 No-Brainer Growth Stocks Are Breaking New Ground: https://g.foolcdn.com/editorial/images/777182/doctor-with-patient-talking.jpg
 

Drugmakers outside the biosimilar or generic-medicine market must constantly innovate to be successful over long periods. Some are better at it than others.

Eli Lilly (NYSE: LLY) and Regeneron Pharmaceuticals (NASDAQ: REGN) have historically been in the more successful group. That's why they are among the most prominent players in the game.

Can Eli Lilly and Regeneron keep this up? Recent developments suggest that the answer is yes. Both companies have announced early positive results for potential groundbreaking therapies for a difficult target: hearing loss. Let's look deeper into these results and their significance for investors.

Continue reading


Source Fool.com

Regeneron Pharmaceuticals Inc. Stock

€928.40
0.870%
The Regeneron Pharmaceuticals Inc. stock is trending slightly upwards today, with an increase of €8.00 (0.870%) compared to yesterday's price.
With 37 Buy predictions and 1 Sell predictions Regeneron Pharmaceuticals Inc. is one of the favorites of our community.
As a result the target price of 962 € shows a slightly positive potential of 3.62% compared to the current price of 928.4 € for Regeneron Pharmaceuticals Inc..
Show more
Like: 0
LLY
Share

Comments

Not a member yet? Sign up for free!